Showing 1,121 - 1,140 results of 3,161 for search '"renal"', query time: 0.08s Refine Results
  1. 1121

    Endovascular salvage of renal and common iliac artery malperfusion following inadvertent hybrid arch dissection stent deployment in the false lumen during repair of type A dissection by Rudra Pandya, BSc, Luc Dubois, MSc, Oonagh Scallan, MD

    Published 2025-02-01
    “…This case report describes the endovascular management of a hybrid arch dissection stent inadvertently deployed in the false lumen during acute type A aortic dissection repair, resulting in renal and lower extremity malperfusion. Prompt identification and intervention are essential to minimize the morbidity and mortality associated with malperfusion. …”
    Get full text
    Article
  2. 1122
  3. 1123
  4. 1124
  5. 1125
  6. 1126
  7. 1127
  8. 1128

    Bone marrow mesenchymal stem cell‐derived exosomes improve renal fibrosis by reducing the polarisation of M1 and M2 macrophages through the activation of EP2 receptors by Yuqing Lu, Lulu Yang, Xiao Chen, Jing Liu, Anqi Nie, Xiaolan Chen

    Published 2022-02-01
    “…Abstract Renal fibrosis is the pathological outcome of most end‐stage renal diseases, yet there are still limited therapeutic options for it. …”
    Get full text
    Article
  9. 1129
  10. 1130
  11. 1131
  12. 1132

    Mas Receptor Blockade Promotes Renal Vascular Response to Ang II after Partial Kidney Ischemia/Reperfusion in a Two-Kidney-One-Clip Hypertensive Rats Model by Farzaneh Karimi, Mehdi Nematbakhsh

    Published 2021-01-01
    “…The renin-angiotensin system (RAS) and hypertension also may be influenced by renal IR injury. In two models of partial renal IR with and without ischemia preconditioning (IPC) and using Mas receptor (MasR) blockade, A779 or its vehicle, the renal vascular responses to angiotensin II (Ang II) administration in two-kidney-one-clip (2K1C) hypertensive rats were determined. …”
    Get full text
    Article
  13. 1133
  14. 1134

    Circular RNA ITCH Is a Tumor Suppressor in Clear Cell Renal Cell Carcinoma Metastasis through miR-106b-5p/PDCD4 Axis by Ping Gao, Yong Huang, Yanmei Hou, Qian Li, Haimei Wang

    Published 2021-01-01
    “…High metastasis of clear cell renal cell carcinoma (ccRCC) significantly influenced survival rate of ccRCC patients. …”
    Get full text
    Article
  15. 1135
  16. 1136

    Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial by Afsoon Emami Naini, Mahnaz Moradi, Mojgan Mortazavi, Asghar Amini Harandi, Mehdi Hadizadeh, Farhad Shirani, Hamed Basir Ghafoori, Pardis Emami Naini

    Published 2012-01-01
    “…In a randomized, double-blinded, placebo-controlled trial, end-stage renal disease (ESRD) patients on hemodialysis received either L-carnitine 1 g/d (n=24) or placebo (27 patients) for 16 weeks. …”
    Get full text
    Article
  17. 1137

    Análise de desempenho dos centros dialíticos no encaminhamento e inscrição em lista de espera pré-transplante renal em Minas Gerais, Brasil, 2015 a 2019 by Cláudio Vitorino Pereira, Isabel Cristina Gonçalves Leite, Mário Círio Nogueira, Gustavo Fernandes Ferreira

    Published 2025-01-01
    “…Resumo: Apesar da relevância do transplante renal, a oferta de órgãos e o processo para inclusão na lista de espera ainda representam entraves. …”
    Get full text
    Article
  18. 1138

    Beating-Heart Coronary Artery Bypass grafting (BH-CABG) in patients with End-Stage Renal Disease (ESRD): comparison of the Society of Thoracic Surgeons (STS) predicted risk with actual outcomes by Louis Samuels, Anastasia Arce, Samiat Agunbiade, Suzanne Raws, Afshin Parsikia

    Published 2025-01-01
    “…Abstract Background End-Stage Renal Disease (ESRD) is an independent risk factor in outcomes for traditional coronary artery bypass grafting (TRAD-CAB) utilizing aortic cross-clamping and cardioplegic arrest. …”
    Get full text
    Article
  19. 1139

    RETRACTED ARTICLE: Association between cytochrome P450 1A1 (CYP1A1) gene polymorphisms and the risk of renal cell carcinoma: a meta-analysis by Fan-dong Meng, Ping Ma, Cheng-guang Sui, Xin Tian, You-hong Jiang

    Published 2015-01-01
    “…To date, many studies have evaluated the association between the CYP1A1 MspI and Ile462Val polymorphisms and renal cell carcinoma (RCC) risk, but the results have been conflicting. …”
    Get full text
    Article
  20. 1140